Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Olli-P Kallioniemi"'
Autor:
Kirsi Syrjäkoski, Tuula Kuukasjärvi, Kati Waltering, Karin Haraldsson, Anssi Auvinen, Åke Borg, Tommi Kainu, Olli-P Kallioniemi, Pasi A. Koivisto
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 6, Iss 5, Pp 541-545 (2004)
The etiology and pathogenesis of male breast cancer (MBC) are poorly known. This is due to the fact that the disease is rare, and large-scale genetic epidemiologic studies have been difficult to carry out. Here, we studied the frequency of eight recu
Externí odkaz:
https://doaj.org/article/0ec309226fc14aeeaeead309f6e3816f
Autor:
Maija Wolf, Spyro Mousses, Sampsa Hautaniemi, Ritva Karhu, Pia Huusko, Minna Allinen, Abdel Elkahloun, Outi Monni, Yidong Chen, Anne Kallioniemi, Olli-P Kallioniemi
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 6, Iss 3, Pp 240-247 (2004)
Identification of target genes for genetic rearrangements in prostate cancer and the impact of copy number changes on gene expression are currently not well understood. Here, we applied high-resolution comparative genomic hybridization (CGH) on cDNA
Externí odkaz:
https://doaj.org/article/c3db72a623b54bb9a18aa4eeada48002
Autor:
Isabelle Rose Leo, Luay Aswad, Matthias Stahl, Elena Kunold, Frederik Post, Tom Erkers, Nona Struyf, Georgios Mermelekas, Rubin Narayan Joshi, Eva Gracia-Villacampa, Päivi Östling, Olli P. Kallioniemi, Katja Pokrovskaja Tamm, Ioannis Siavelis, Janne Lehtiö, Mattias Vesterlund, Rozbeh Jafari
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-19 (2022)
Childhood acute lymphoblastic leukemia is characterised by a range of genetic aberrations. Here, the authors use multi-omics profiling of ALL cell lines to connect molecular phenotypes and drug responses to provide an interactive resource of drug sen
Externí odkaz:
https://doaj.org/article/9c69031e6a7f4af09b4fad9d64e4c2b5
Autor:
Samuel Kaski, Astrid Murumägi, Disha Malani, Olli-P. Kallioniemi, Tero Aittokallio, Suleiman A. Khan, Muhammad Ammad-ud-din
Publikováno v:
Bioinformatics. 32(17):i455-i463
A key goal of computational personalized medicine is to systematically utilize genomic and other molecular features of samples to predict drug responses for a previously unseen sample. Such predictions are valuable for developing hypotheses for selec
Autor:
Päivi Östling, Khalid Saeed, Bychkov Dmitrii, Potdar Swapnil, Saarela Jani, Olli-P. Kallioniemi, Tero Aittokallio, John Patrick Mpindi, Krister Wennerberg
Publikováno v:
Bioinformatics
Motivation: Most data analysis tools for high-throughput screening (HTS) seek to uncover interesting hits for further analysis. They typically assume a low hit rate per plate. Hit rates can be dramatically higher in secondary screening, RNAi screenin
Autor:
Tuomo Laitinen, Muhammad Ammad-ud-din, Antti Poso, Olli-P. Kallioniemi, Krister Wennerberg, Mehmet Gönen, Elisabeth Georgii, Samuel Kaski
Publikováno v:
Journal of Chemical Information and Modeling. 54:2347-2359
With data from recent large-scale drug sensitivity measurement campaigns, it is now possible to build and test models predicting responses for more than one hundred anticancer drugs against several hundreds of human cancer cell lines. Traditional qua
Autor:
Anna-Kaarina Järvinen, Olli-P. Kallioniemi, Sampsa Hautaniemi, Outi Monni, Henrik Edgren, Janna Saarela, Petri Auvinen
Publikováno v:
Järvinen, A-K, Hautaniemi, S, Edgren, H, Auvinen, P, Saarela, J, Kallioniemi, O & Monni, O 2004, ' Are data from different gene expression microarray platforms comparable? ', Genomics, vol. 83, no. 6, pp. 1164-1168 . https://doi.org/10.1016/j.ygeno.2004.01.004
Many commercial and custom-made microarray formats are routinely used for large-scale gene expression surveys. Here, we sought to determine the level of concordance between microarray platforms by analyzing breast cancer cell lines with in situ synth
Publikováno v:
TARGETS. 2:147-153
The most effective targeted cancer therapies have arisen from research into genetically altered oncogenes, including BCR-ABL, HER2, RAS and EGFR. Recent advances in cancer genetics have identified many regions of the genome that undergo amplification
Autor:
Johanna Schleutker, Tomi-Pekka Tuomainen, Eija H. Seppälä, Pekka Uimari, Mika P. Matikainen, Terho Lehtimäki, Jari Kaikkonen, Olli-P. Kallioniemi, Anna Hakkarainen, Marja Marchesani, Jukka T. Salonen, Eero Pukkala
Publikováno v:
Marchesani, M, Hakkarainen, A, Tuomainen, T-P, Kaikkonen, J, Pukkala, E, Uimari, P, Seppälä, E, Matikainen, M, Kallioniemi, O, Schleutker, J, Lehtimäki, T & Salonen, J 2003, ' New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men ', Journal of the National Cancer Institute, vol. 95, no. 11, pp. 812-818 . https://doi.org/10.1093/jnci/95.11.812
University of Helsinki
University of Helsinki
Background: Human serum paraoxonase eliminates carcinogenic lipid-soluble radicals. Because expression of the main human paraoxonase gene PON1 varies widely in humans, certain PON1 polymorphisms might be associated with increased risks of cancer. We
Autor:
Olli-P. Kallioniemi, Jaakko Astola, Anne Kallioniemi, Maija Wolf, Jimmy Ruiz, Olli Yli-Harja, Spyro Mousses, Päivikki Kauraniemi, Sampsa Hautaniemi
Publikováno v:
Machine Learning. 52:45-66
cDNA microarrays permit massively parallel gene expression analysis and have spawned a new paradigm in the study of molecular biology. One of the significant challenges in this genomic revolution is to develop sophisticated approaches to facilitate t